IN2014KN00742A - - Google Patents
Info
- Publication number
- IN2014KN00742A IN2014KN00742A IN742KON2014A IN2014KN00742A IN 2014KN00742 A IN2014KN00742 A IN 2014KN00742A IN 742KON2014 A IN742KON2014 A IN 742KON2014A IN 2014KN00742 A IN2014KN00742 A IN 2014KN00742A
- Authority
- IN
- India
- Prior art keywords
- tbi
- methods
- tsi
- compositions
- therapeutics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/046—Thyroid disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/228,705 US8986937B2 (en) | 2011-09-09 | 2011-09-09 | Compositions and methods for detecting autoantibodies |
| PCT/US2011/050976 WO2013036239A1 (fr) | 2011-09-09 | 2011-09-09 | Compositions et procédés de détection d'auto-anticorps |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014KN00742A true IN2014KN00742A (fr) | 2015-10-02 |
Family
ID=47830166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN742KON2014 IN2014KN00742A (fr) | 2011-09-09 | 2011-09-09 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US8986937B2 (fr) |
| EP (1) | EP2753928B1 (fr) |
| JP (1) | JP5908590B2 (fr) |
| KR (1) | KR101872060B1 (fr) |
| CN (1) | CN103975239B (fr) |
| DK (1) | DK2753928T3 (fr) |
| IN (1) | IN2014KN00742A (fr) |
| PL (1) | PL2753928T3 (fr) |
| WO (1) | WO2013036239A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020050208A1 (fr) * | 2018-09-05 | 2020-03-12 | ヤマサ醤油株式会社 | Procédé et kit de mesure rapide de l'activité d'un auto-anticorps par rapport au récepteur tsh |
| JP2022524779A (ja) * | 2019-03-12 | 2022-05-10 | クイデル コーポレーション | 自己抗体を検出するための組成物、キット、及び方法 |
| JP7212955B2 (ja) * | 2020-12-28 | 2023-01-26 | ヤマサ醤油株式会社 | 甲状腺刺激ホルモン受容体阻害性自己抗体の活性測定法およびキット |
| CN113686841B (zh) * | 2021-09-01 | 2023-06-30 | 北京利德曼生化股份有限公司 | 定量检测甲状腺素结合力试剂盒及其制备方法、检测方法 |
| WO2023214183A2 (fr) | 2022-05-06 | 2023-11-09 | Antibody Analytics Limited | Systèmes de proximité induits chimiquement |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4537573B2 (ja) * | 1997-09-19 | 2010-09-01 | プロメガ・コーポレイシヨン | 熱安定ルシフェラーゼと生産方法 |
| US6747139B1 (en) | 1997-11-05 | 2004-06-08 | Quest Diagnostics Investments, Inc. | Nucleic acid encoding human thyrotropin receptor |
| US8563257B2 (en) | 2000-03-30 | 2013-10-22 | Diagnostic Hybrids, Inc. | Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease and assess disease severity |
| US8293879B2 (en) * | 2000-03-30 | 2012-10-23 | Diagnostic Hybrids, Inc. | Methods of using chimeric receptors to identify autoimmune disease |
| GB0516527D0 (en) * | 2005-08-11 | 2005-09-21 | Arpi Matossian Rogers | Peptides |
| EP1951753A2 (fr) | 2005-11-21 | 2008-08-06 | Dr. Fenning Biomed GmbH | Polypeptides recombines et procedes permettant de detecter et/ou de quantifier les auto-anticorps diriges contres les recepteurs de la tsh |
| US8840891B2 (en) * | 2007-02-15 | 2014-09-23 | Rsr Limited | Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| TW200918058A (en) * | 2007-08-31 | 2009-05-01 | Organon Nv | TSH receptor antagonizing tetrahydroquinoline compounds |
| US7799532B2 (en) * | 2008-11-12 | 2010-09-21 | Hemopet | Detection and measurement of thyroid hormone autoantibodies |
| PL2367850T3 (pl) * | 2008-12-24 | 2015-12-31 | Rsr Ltd | Ludzkie przeciwciała przeciwko TSHR |
-
2011
- 2011-09-09 EP EP11872018.4A patent/EP2753928B1/fr active Active
- 2011-09-09 US US13/228,705 patent/US8986937B2/en active Active
- 2011-09-09 PL PL11872018T patent/PL2753928T3/pl unknown
- 2011-09-09 CN CN201180074180.2A patent/CN103975239B/zh active Active
- 2011-09-09 DK DK11872018.4T patent/DK2753928T3/en active
- 2011-09-09 WO PCT/US2011/050976 patent/WO2013036239A1/fr active Application Filing
- 2011-09-09 KR KR1020147009182A patent/KR101872060B1/ko active IP Right Grant
- 2011-09-09 IN IN742KON2014 patent/IN2014KN00742A/en unknown
- 2011-09-09 JP JP2014529656A patent/JP5908590B2/ja active Active
-
2015
- 2015-02-18 US US14/625,086 patent/US20150233914A1/en not_active Abandoned
-
2020
- 2020-05-11 US US16/871,554 patent/US20200340991A1/en active Pending
-
2023
- 2023-12-06 US US18/530,800 patent/US20240133882A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN103975239A (zh) | 2014-08-06 |
| EP2753928B1 (fr) | 2018-02-07 |
| US8986937B2 (en) | 2015-03-24 |
| US20150233914A1 (en) | 2015-08-20 |
| US20130065252A1 (en) | 2013-03-14 |
| EP2753928A4 (fr) | 2015-05-27 |
| US20240133882A1 (en) | 2024-04-25 |
| US20200340991A1 (en) | 2020-10-29 |
| JP2014529993A (ja) | 2014-11-17 |
| WO2013036239A1 (fr) | 2013-03-14 |
| JP5908590B2 (ja) | 2016-04-26 |
| CN103975239B (zh) | 2016-08-24 |
| PL2753928T3 (pl) | 2018-07-31 |
| KR101872060B1 (ko) | 2018-06-27 |
| DK2753928T3 (en) | 2018-05-22 |
| KR20140084022A (ko) | 2014-07-04 |
| EP2753928A1 (fr) | 2014-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015031808A3 (fr) | Procédés de diagnostic et compositions pour le traitement d'un glioblastome | |
| EP3186397C0 (fr) | Utilisation de biomarqueurs de cellules circulant dans le sang pour la détection et le diagnostic de maladies, et leurs procédés d'isolement | |
| MX2012013327A (es) | Anticuerpo anti-humano trop-2 que tiene actividad. | |
| MX356802B (es) | Marcadores biologicos para identificar pacientes para tratamiento con antagonistas de vegf. | |
| WO2013030578A3 (fr) | Procédé de détection de nucléosomes | |
| ZA201202076B (en) | Anti-cmet antibody and its use for the detection and the diagnosis of cancer | |
| MX2013000674A (es) | Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer. | |
| MX2020001160A (es) | Anticuerpos y ensayos para la deteccion del receptor 1 de folato. | |
| EP2569630A4 (fr) | Profils d'auto-anticorps diagnostiques pour détecter et diagnostiquer des maladies neurodégénératives | |
| MX343327B (es) | Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. | |
| DK2900279T3 (da) | Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer | |
| HK1208813A1 (en) | Diagnosis, prevention and treatment of diseases of the joint | |
| DK3088421T3 (da) | Monoklonale antistoffer til anvendelse i diagnose og terapi af cancer-sygdomme og autoimmunsygdomme | |
| HK1247287A1 (zh) | 檢測和定量il-13的方法和在診斷和治療th2相關疾病中的用途 | |
| EP2811832A4 (fr) | Utilisation de laquinimod pour le traitement de patients souffrant de la maladie de crohn pour lesquels la thérapie anti-tnf de première intention a échoué | |
| IN2012DN06309A (fr) | ||
| EP2631649A4 (fr) | Procédé et dispositif de diagnostic rapide de maladies dans des échantillons fécaux | |
| IN2014KN00742A (fr) | ||
| EP3628326C0 (fr) | Méthodes et substances permettant de traiter la maladie de pompe | |
| MX2021009528A (es) | Prueba de diagnostico basada en fragmento de rgma. | |
| WO2015013508A3 (fr) | Procédés permettant de diagnostiquer et de traiter une maladie du système immunitaire | |
| EP2524219A4 (fr) | Procédés de détection et d'analyse de biomolécules et de complexes de biomolécules (bmc) et leur utilisation pour la recherche et le diagnostic médical | |
| WO2016014799A9 (fr) | Facteur de croissance épidermique et inhibition des points de contrôle immunitaire en immunothérapie anticancéreuse | |
| WO2012075023A3 (fr) | Néoanticorps pour le diagnostic d'une lésion tissulaire | |
| PH12017502099A1 (en) | Methods for diagnosing and assessing treatment for cushing's syndrome |